[HTML][HTML] The effect of dapagliflozin treatment on epicardial adipose tissue volume
T Sato, Y Aizawa, S Yuasa, S Kishi, K Fuse… - Cardiovascular …, 2018 - Springer
Background Glycosuria produced by sodium–glucose co-transporter-2 (SGLT-2) inhibitors is
associated with weight loss. SGLT-2 inhibitors reportedly might reduce the occurrence of …
associated with weight loss. SGLT-2 inhibitors reportedly might reduce the occurrence of …
[引用][C] The effect of dapagliflozin treatment on epicardial adipose tissue volume
T Sato, Y Aizawa, S Yuasa, S Kishi, K Fuse… - Cardiovascular …, 2018 - cir.nii.ac.jp
The effect of dapagliflozin treatment on epicardial adipose tissue volume | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
The effect of dapagliflozin treatment on epicardial adipose tissue volume
T Sato, Y Aizawa, S Yuasa, S Kishi, K Fuse… - Cardiovascular …, 2018 - go.gale.com
Obesity and diabetes mellitus (DM) are fast growing public health problems in industrialized
countries [1] and are associated with cardiovascular complications [2]. Adipose tissue …
countries [1] and are associated with cardiovascular complications [2]. Adipose tissue …
[HTML][HTML] The effect of dapagliflozin treatment on epicardial adipose tissue volume
T Sato, Y Aizawa, S Yuasa, S Kishi… - Cardiovascular …, 2018 - cardiab.biomedcentral.com
Glycosuria produced by sodium–glucose co-transporter-2 (SGLT-2) inhibitors is associated
with weight loss. SGLT-2 inhibitors reportedly might reduce the occurrence of cardiovascular …
with weight loss. SGLT-2 inhibitors reportedly might reduce the occurrence of cardiovascular …
The effect of dapagliflozin treatment on epicardial adipose tissue volume
T Sato, Y Aizawa, S Yuasa, S Kishi, K Fuse… - Cardiovascular …, 2018 - infona.pl
Background Glycosuria produced by sodium–glucose co-transporter-2 (SGLT-2) inhibitors is
associated with weight loss. SGLT-2 inhibitors reportedly might reduce the occurrence of …
associated with weight loss. SGLT-2 inhibitors reportedly might reduce the occurrence of …
The effect of dapagliflozin treatment on epicardial adipose tissue volume
T Sato, Y Aizawa, S Yuasa, S Kishi… - Cardiovascular …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Glycosuria produced by sodium-glucose co-transporter-2 (SGLT-2) inhibitors is
associated with weight loss. SGLT-2 inhibitors reportedly might reduce the occurrence of …
associated with weight loss. SGLT-2 inhibitors reportedly might reduce the occurrence of …
The effect of dapagliflozin treatment on epicardial adipose tissue volume.
T Sato, Y Aizawa, S Yuasa, S Kishi, K Fuse… - Cardiovascular …, 2018 - europepmc.org
Background Glycosuria produced by sodium-glucose co-transporter-2 (SGLT-2) inhibitors is
associated with weight loss. SGLT-2 inhibitors reportedly might reduce the occurrence of …
associated with weight loss. SGLT-2 inhibitors reportedly might reduce the occurrence of …
The effect of dapagliflozin treatment on epicardial adipose tissue volume.
T Sato, Y Aizawa, S Yuasa, S Kishi… - Cardiovascular …, 2018 - search.ebscohost.com
Background: Glycosuria produced by sodium-glucose co-transporter-2 (SGLT-2) inhibitors is
associated with weight loss. SGLT-2 inhibitors reportedly might reduce the occurrence of …
associated with weight loss. SGLT-2 inhibitors reportedly might reduce the occurrence of …
[HTML][HTML] The effect of dapagliflozin treatment on epicardial adipose tissue volume
T Sato, Y Aizawa, S Yuasa, S Kishi, K Fuse… - Cardiovascular …, 2018 - ncbi.nlm.nih.gov
Background Glycosuria produced by sodium–glucose co-transporter-2 (SGLT-2) inhibitors is
associated with weight loss. SGLT-2 inhibitors reportedly might reduce the occurrence of …
associated with weight loss. SGLT-2 inhibitors reportedly might reduce the occurrence of …
The effect of dapagliflozin treatment on epicardial adipose tissue volume.
T Sato, Y Aizawa, S Yuasa, S Kishi, K Fuse… - Cardiovascular …, 2018 - europepmc.org
Background Glycosuria produced by sodium-glucose co-transporter-2 (SGLT-2) inhibitors is
associated with weight loss. SGLT-2 inhibitors reportedly might reduce the occurrence of …
associated with weight loss. SGLT-2 inhibitors reportedly might reduce the occurrence of …